Terms: = Sarcomas AND KAT6A
4 results:
1. kat6a::EP300 fusion in congenital myeloid sarcoma: Yet another novel molecular marker indicating spontaneous remission?: A case report.
Hosahalli Vasanna S; Shah SD; Rohr BR; Roche B; Meyerson H; Pateva I
Medicine (Baltimore); 2023 Jul; 102(30):e34258. PubMed ID: 37505185
[TBL] [Abstract] [Full Text] [Related]
2. A Case of Neonatal Myeloid Sarcoma.
Burdick H; Bormann J; Wagner K; Kerkvliet A
S D Med; 2022 Sep; 75(9):390-391. PubMed ID: 36881822
[TBL] [Abstract] [Full Text] [Related]
3. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma.
Zhao J; Xiang C; Zhao R; Guo P; Zheng J; Han-Zhang H; Yu K; Zhang J; Han Y
BMC Cancer; 2020 Mar; 20(1):248. PubMed ID: 32209061
[TBL] [Abstract] [Full Text] [Related]